Breaking News Instant updates and real-time market news.

EMR

Emerson

$59.73

0.03 (0.05%)

07:11
01/03/19
01/03
07:11
01/03/19
07:11

Emerson upgraded to Outperform on expectations for oil recovery at Credit Suisse

As previously reported, Credit Suisse analyst John Walsh upgraded Emerson to Outperform from Neutral on expectations for an oil price recovery in early Q2, strong E&C backlogs, and attractive free cash flow generation. The analyst lowered his price target on the shares to $70 from $74.

EMR Emerson
$59.73

0.03 (0.05%)

01/03/19
FBCO
01/03/19
UPGRADE
FBCO
Outperform
Emerson upgraded to Outperform from Neutral at Credit Suisse
12/19/18
WELS
12/19/18
NO CHANGE
Target $69
WELS
Market Perform
Emerson price target lowered to $69 from $77 at Wells Fargo
Wells Fargo analyst Richard Kwas lowered his price target for Emerson to $69 from $77 to reflect the decline in market valuations. After hosting CEO Farr for investor meetings, the analyst notes that Q1 is on plan and 2019 revenue/earnings guidance sufficiently encompasses current macro crosswinds. But, EPS upside potential looks limited right now, Kwas contends, adding that the company will have a better feel for underlying demand trends by mid-late January. He reiterates a Market Perform rating on the shares.
12/17/18
JPMS
12/17/18
NO CHANGE
Target $87
JPMS
Overweight
Emerson selloff on drop in oil price overdone, says JPMorgan
JPMorgan analyst Stephen Tusa thinks the negative reaction to Emerson Electric's stock price over the last several weeks to the latest retreat in oil and gas prices is overdone "with valuation at relative historic lows." Emerson's "diversified" Automated Solutions platform and standing budgets that show growth in capital spending within the company's diversified process verticals in 2019 indicate the story is not all about oil price and upstream markets, Tusa tells investors in a research note. Further, the company's customers themselves are in better financial shape, with a more conservative starting point on budgets, a big difference between now and the prior peak in 2014, argues the analyst. He reiterates an Overweight rating on Emerson with an $87 price target.
12/17/18
LEHM
12/17/18
DOWNGRADE
Target $71
LEHM
Equal Weight
Barclays downgrades Emerson to Equal Weight on weakening cyclical backdrop
Barclays analyst Julian Mitchell downgraded Emerson Electric to Equal Weight and lowered his price target for the shares to $71 from $85. There are "clearly more risks embedded in the stock price today than a few months ago," Mitchell tells investors in a research note. The analyst thinks Emerson's sales growth will decelerate and that the company unlikely has "sufficient self-help drivers" to yield above-average earnings growth. While Emerson's operational management is best-in-class, the cyclical backdrop is deteriorating, says Mitchell.

TODAY'S FREE FLY STORIES

GRUB

GrubHub

$42.27

2.04 (5.07%)

14:55
12/12/19
12/12
14:55
12/12/19
14:55
Conference/Events
GrubHub participates in a conference call with Benchmark »

Services/Media Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COST

Costco

$297.17

1.95 (0.66%)

14:49
12/12/19
12/12
14:49
12/12/19
14:49
Options
Costco options imply 5.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

NVST

Envista

$28.37

0.19 (0.67%)

14:45
12/12/19
12/12
14:45
12/12/19
14:45
Options
Envista Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRX

Brixmor

$21.07

-0.36 (-1.68%)

14:44
12/12/19
12/12
14:44
12/12/19
14:44
Conference/Events
Brixmor management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 11

    Feb

PD

PagerDuty

$22.13

-0.235 (-1.05%)

14:40
12/12/19
12/12
14:40
12/12/19
14:40
Conference/Events
PagerDuty management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Dec

SPY

SPDR S&P 500 ETF Trust

$315.97

1.56 (0.50%)

, SPX

S&P 500

$0.00

(0.00%)

14:39
12/12/19
12/12
14:39
12/12/19
14:39
Periodicals
U.S. negotiators reach China trade deal, pending Trump approval, Bloomberg says »

U.S. negotiators have…

SPY

SPDR S&P 500 ETF Trust

$315.97

1.56 (0.50%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,752.74

3.63 (0.21%)

14:34
12/12/19
12/12
14:34
12/12/19
14:34
Periodicals
Amazon to open distribution center in Pernambuco, Brazil in 2020, Reuters says »

Amazon said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$316.10

1.69 (0.54%)

, SPX

S&P 500

$0.00

(0.00%)

14:34
12/12/19
12/12
14:34
12/12/19
14:34
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

U.S. has deal 'in…

SPY

SPDR S&P 500 ETF Trust

$316.10

1.69 (0.54%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMNFF

MedMen

$0.00

(0.00%)

14:25
12/12/19
12/12
14:25
12/12/19
14:25
Conference/Events
MedMen management to meet with Cantor Fitzgerald »

Analyst Pablo Zuanic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FB

Facebook

$200.86

-1.37 (-0.68%)

14:22
12/12/19
12/12
14:22
12/12/19
14:22
Periodicals
FTC considers injunction to block Facebook policies on app integration, WSJ says »

The Federal Trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$5.00

1.515 (43.47%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LUV

Southwest

$54.65

0.67 (1.24%)

, BA

Boeing

$346.36

-3.64 (-1.04%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Periodicals
Southwest weighs another delay in 737 MAX's return to schedule, Bloomberg says »

Southwest Airlines (LUV)…

LUV

Southwest

$54.65

0.67 (1.24%)

BA

Boeing

$346.36

-3.64 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 23

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/12/19
12/12
14:17
12/12/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$200.80

-1.43 (-0.71%)

14:16
12/12/19
12/12
14:16
12/12/19
14:16
Periodicals
FTC considering injunction against Facebook, WSJ says »

The potential FTC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/12/19
12/12
14:16
12/12/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITCI

Intra-Cellular

$12.67

0.53 (4.37%)

14:15
12/12/19
12/12
14:15
12/12/19
14:15
Options
Intra Cellular Therapies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Dec

TISI

Team

$15.98

-0.03 (-0.19%)

14:14
12/12/19
12/12
14:14
12/12/19
14:14
Initiation
Team initiated  »

Team initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

, MO

Altria Group

$50.38

0.075 (0.15%)

14:11
12/12/19
12/12
14:11
12/12/19
14:11
Periodicals
CDC says many brands likely responsible for vaping-related injuries, Verge says »

The Centers for Disease…

BTI

British American Tobacco

$39.37

-0.12 (-0.30%)

MO

Altria Group

$50.38

0.075 (0.15%)

PM

Philip Morris

$84.20

-0.8 (-0.94%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NXGN

NextGen Healthcare

$17.10

-1.01 (-5.58%)

14:11
12/12/19
12/12
14:11
12/12/19
14:11
Hot Stocks
NextGen Healthcare down 6% after guiding 'relatively flat' earnings until FY23 »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AMRX

Amneal Pharmaceuticals

$5.04

1.555 (44.62%)

14:09
12/12/19
12/12
14:09
12/12/19
14:09
Downgrade
Amneal Pharmaceuticals rating change  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXGN

NextGen Healthcare

$17.39

-0.72 (-3.98%)

14:08
12/12/19
12/12
14:08
12/12/19
14:08
Earnings
NextGen Healthcare lowers FY20 EPS outlook, raises low-end of FY20 revenue view »

In presentation slides…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

APO

Apollo Global

$44.31

-0.66 (-1.47%)

, GE

General Electric

$11.36

0.375 (3.42%)

14:06
12/12/19
12/12
14:06
12/12/19
14:06
Hot Stocks
Apollo, Athene close the acquisition of GE Capital's PK AirFinance debt business »

Apollo Global Management…

APO

Apollo Global

$44.31

-0.66 (-1.47%)

GE

General Electric

$11.36

0.375 (3.42%)

ATH

Athene Holding

$45.09

1.12 (2.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 26

    Feb

CIEN

Ciena

$41.74

6.29 (17.74%)

14:06
12/12/19
12/12
14:06
12/12/19
14:06
Recommendations
Ciena analyst commentary  »

Ciena's long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BMRN

BioMarin

$80.03

1.25 (1.59%)

14:05
12/12/19
12/12
14:05
12/12/19
14:05
Options
BioMarin call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

, AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

13:59
12/12/19
12/12
13:59
12/12/19
13:59
Recommendations
TherapeuticsMD, Amneal Pharmaceuticals, Merck analyst commentary  »

Stifel says…

TXMD

TherapeuticsMD

$2.39

0.01 (0.42%)

AMRX

Amneal Pharmaceuticals

$5.15

1.66 (47.63%)

MRK

Merck

$89.27

0.31 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.